Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61–20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial
乔垣结衣
25天前
51
10
已完结
1. 系统已在2025-04-02 17:46:24对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S1470-2045(24)00757-5
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204524007575
其他信息:
出版社: Elsevier BV
作者: Nicholas Zdenkowski; Marion J J Kuper-Hommel; Samuel M Niman; Prudence A Francis; Sally Baron-Hay; William Fox; Alexander M Menzies; Rebecca Angus; Kevin Punie; Sarah Zardawi; Meredith M Regan; Sherene Loi
